Live Updates: COVID-19 Cases
  • World 30,549,837
    World
    Confirmed: 30,549,837
    Active: 7,390,270
    Recovered: 22,206,538
    Death: 953,029
  • USA 6,893,879
    USA
    Confirmed: 6,893,879
    Active: 2,521,056
    Recovered: 4,170,202
    Death: 202,621
  • India 5,274,606
    India
    Confirmed: 5,274,606
    Active: 1,020,825
    Recovered: 4,168,679
    Death: 85,102
  • Brazil 4,466,828
    Brazil
    Confirmed: 4,466,828
    Active: 578,543
    Recovered: 3,753,082
    Death: 135,203
  • Russia 1,091,186
    Russia
    Confirmed: 1,091,186
    Active: 170,784
    Recovered: 901,207
    Death: 19,195
  • Peru 750,098
    Peru
    Confirmed: 750,098
    Active: 124,439
    Recovered: 594,513
    Death: 31,146
  • Mexico 684,113
    Mexico
    Confirmed: 684,113
    Active: 123,518
    Recovered: 488,416
    Death: 72,179
  • Spain 659,334
    Spain
    Confirmed: 659,334
    Active: 628,839
    Recovered: ?
    Death: 30,495
  • South Africa 655,572
    South Africa
    Confirmed: 655,572
    Active: 54,497
    Recovered: 585,303
    Death: 15,772
  • Chile 442,827
    Chile
    Confirmed: 442,827
    Active: 14,647
    Recovered: 415,981
    Death: 12,199
  • France 428,696
    France
    Confirmed: 428,696
    Active: 306,761
    Recovered: 90,840
    Death: 31,095
  • Iran 416,198
    Iran
    Confirmed: 416,198
    Active: 36,741
    Recovered: 355,505
    Death: 23,952
  • UK 385,936
    UK
    Confirmed: 385,936
    Active: 344,204
    Recovered: ?
    Death: 41,732
  • Bangladesh 345,805
    Bangladesh
    Confirmed: 345,805
    Active: 88,589
    Recovered: 252,335
    Death: 4,881
  • Saudi Arabia 328,720
    Saudi Arabia
    Confirmed: 328,720
    Active: 15,938
    Recovered: 308,352
    Death: 4,430
  • Pakistan 304,386
    Pakistan
    Confirmed: 304,386
    Active: 6,295
    Recovered: 291,683
    Death: 6,408
  • Turkey 299,810
    Turkey
    Confirmed: 299,810
    Active: 27,628
    Recovered: 264,805
    Death: 7,377
  • Italy 294,932
    Italy
    Confirmed: 294,932
    Active: 42,457
    Recovered: 216,807
    Death: 35,668
  • Germany 270,653
    Germany
    Confirmed: 270,653
    Active: 19,890
    Recovered: 241,300
    Death: 9,463
  • Canada 141,565
    Canada
    Confirmed: 141,565
    Active: 8,852
    Recovered: 123,512
    Death: 9,201
  • Netherlands 90,047
    Netherlands
    Confirmed: 90,047
    Active: 83,774
    Recovered: ?
    Death: 6,273
  • China 85,255
    China
    Confirmed: 85,255
    Active: 165
    Recovered: 80,456
    Death: 4,634
  • Australia 26,861
    Australia
    Confirmed: 26,861
    Active: 2,169
    Recovered: 23,855
    Death: 837
  • S. Korea 22,783
    S. Korea
    Confirmed: 22,783
    Active: 2,635
    Recovered: 19,771
    Death: 377
  • New Zealand 1,809
    New Zealand
    Confirmed: 1,809
    Active: 70
    Recovered: 1,714
    Death: 25

Scientists map body-wide production of a protein with “important role” in COVID-19

Author at TechGenyz Health
New Protein on COVID
A picture of employee are wearing mask credit: @Freepik

Scientists have analysed the presence throughout the human body of a protein which the novel coronavirus uses to enter host cells, and have found that it is produced only at “very low levels, if at all,” in the respiratory system, an advance which highlights the need for further studies to reassess the biological mechanisms responsible for COVID-19.

The study, published in the journal Molecular Systems Biology, presented a systematic evaluation of the production of ACE2 — the ‘coronavirus entry gate’ protein — in more than 150 cell types in the human body.

It noted that the protein expression was consistently high in the intestines, kidney, gallbladder, heart, male reproductive organs, placenta, eye and vascular tissues, while it was limited in the respiratory system.

Previous studies have indicated that ACE2 protein is highly expressed in the human lung. But these expression profiles have not been reliably presented along with tissues and organs from the entire human body, or based on several different datasets.- Cecilia Lindskog, study senior author from Uppsala University in Sweden.

“Here, in contrast to previous studies, we were able to confidently show that no ACE2 protein is present, or that it occurs at only very low levels, in the normal respiratory system,” Lindskog said.

Earlier studies had suggested that the novel coronavirus SARS-CoV-2 employs ACE2 for host cell entry and that penetration of the virus via this receptor would explain the severe clinical manifestations observed in various tissues and organs, including the respiratory system.

Considering the clinical manifestations of COVID-19, with acute respiratory distress syndrome and extensive damage to the lung parenchyma, the results highlight the need for further study of the biological mechanisms responsible for COVID-19 infection and disease progression. Cecilia Lindskog, study senior author from Uppsala University in Sweden.

“Further studies addressing the dynamic regulation of ACE2, and to confirm whether the low ACE2 expression in the human respiratory system is sufficient for SARS-CoV-2 infection, or whether other factors are needed for host cell entry, are urgently needed,” she added.

Career

Subscribe